, & Knudsen, L
doi: 10.1002/rmv.615 51 ParkCHKimKT
reports receiving personal fees for consulting and/or speaking from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Medscape, Merck, Novo Nordisk, Sanofi, and UpToDate
The FDA has cautioned that compounded GLP-1 formulations may carry potential risks, including variability in potency and purity
IAH increases the risk of Level 3 hypoglycaemia by sixfold [114] and may lead to the person with diabetes omitting insulin injections intentionally or loosening tight glucose management to prevent their occurrence
The Transportation Security Administration (TSA) permits passengers to carry medically necessary liquids, including injectable medications, in quantities exceeding the standard 3.4-ounce (100 milliliters) limit for carry-on luggage